-
Is it possible to make obesity no longer a trigger for diabetes
Time of Update: 2023-02-01
Researchers at Washington University School of Medicine in St. Louis have found a defect in an enzyme called APT1 that interferes with the ability to secrete insulin, causing type 2 diabetes in overweight or obese people.
-
PVC market resources are not much, quotations remain firm
Time of Update: 2022-12-03
PVCUpstream market: International crude oil futures prices rose sharply, WTI crude oil November futures settled at $45.
PVCUpstream market: International crude oil futures prices rose sharply, WTI crude oil November futures settled at $45.
-
Eur J Endocrinol: Common causes of type 1 diabetes and Hashimoto's thyroiditis - a population-based twin study
Time of Update: 2022-11-14
Objective: The purpose of this study was to assess the common familial risk of type 1 diabetes and Hashimoto's thyroiditis and to quantify the common genetic and environmental sources of the disease using a large population-based cohort of twins.
-
Diabetes must know! This vitamin can lower blood sugar and prevent complications, which is indispensable for the body
Time of Update: 2022-11-01
of type 2 diabetesToday,we will share vitamin D related content with you in combination with the latest papers and the "Chinese Guidelines for Nutritional Treatment of Diabetes Medicine (2022 Edition)".
-
NEJM: Better sugar control, bionic pancreas is expected to be an effective treatment for type 1 diabetes
Time of Update: 2022-11-01
Recently, the New England Journal of Medicine (NEJM) published the results of a multicenter randomized trial evaluating the effectiveness and safety of bionic pancreatic devices (insulin infusion only, no glucagon) in adults with type 1 diabetes and children 6 years of age and older.
-
Nature Sub-Journal: Closed-loop insulin delivery systems may help with brain development in children with type 1 diabetes
Time of Update: 2022-09-15
This is a proof-of-concept pilot study that reports that a mixed closed-loop insulin delivery system can reduce the occurrence of hyperglycemia and glucose variants, or improve brain development and cognitive function in adolescents with type 1 diabetes.
-
At the end of 2021, I will give you a list of these 11 guidelines/consensus on endocrinology
Time of Update: 2022-01-09
In order to help Chinese clinicians to standardize the clinical treatment of T2DM alleviation in overweight or obese T2DM patients, so that patients can obtain safe and effective intervention measures, in September this year, the "China Expert Consensus on Alleviating Type 2 Diabetes" was officially launched .
-
Diabetologia: new effect of fenofibrate: delay the progression of diabetic retinopathy by increasing circulating hematopoietic stem cells
Time of Update: 2021-09-03
Here, we plot the fenofibrate and placebo groups observed in this study,As HSPC levels change from baseline, the estimated rate of progression of diabetic retinopathy changes .
-
Sub-Journal of "Nature": Middle-aged people sleep less, old age is prone to dementia
Time of Update: 2021-05-22
After adjusting for behavioral and health-related factors in the above model, the researchers only found that in the study population of 50 and 60 years old, compared with participants who slept for about 7 hours, the daily sleep time was less than or equal to 6 Hours are associated with a 22% and 37% increase in the risk of dementia.
-
Diabetes Obes Metab: Prevalence and progression of chronic kidney disease in patients with type 2 diabetes
Time of Update: 2021-04-22
Recently, Diabetes Obesity & Metabolism, an authoritative journal in the field of metabolic endocrine diseases, published a research article on this global, 3-year prospective observational study of the initiation of second-line hypoglycemic therapy for patients with type 2 diabetes (T2D) Researchers aim to report changes in the prevalence and severity of chronic kidney disease (CKD).
-
EMA accepts license extensions from Invokana and Vokanamet
Time of Update: 2021-02-24
Mundipharma announced that the European Medicines Agency (EMA) had received a deferred licence from Invokana and Vokanamet (canagliflozin and metformin) for the treatment of stage 2 or stage 3 chronic kidney disease (CKD) and albuminuria as standard assisted type 2 diabetes patients.
-
Well-known broker Yang naively announced that "cut stomach" weight loss! Hangzhou mother also hesitated to do for her daughter, the doctor said
Time of Update: 2020-09-03
Photo source: Yang innocent micro-blogging coincidentally, Qian newspaper reporter contacted Zheng director, her clinic happens to have a fat girl from small fat to large in consultation gastric surgery, "gastric surgery has been a mature technology, is now more and more people accept." is also an option for obese patients who are exhausted from other weight loss methods.
-
Diabetes Obes Metab: The effect of cylometazole on the volume of cervical artery plaques in patients with type 2 diabetes
Time of Update: 2020-07-29
!---- recently published a study in the journal Diabetes Obesity and Metabolism, researchers conducted a prospective random study to assess the efficacy of silatase, a phosphoric disterase III inhibit
-
CELL METAB: Gut Microbiome in Prediabetes and Diabetes: A Population-Based Crossprofile Study
Time of Update: 2020-07-16
The link between the !---- and type 2 diabetes (T2D) deserves further investigation, as studies have shown the mixed effects of the gut microbiome's anti-diabetes treatment recently, researchers anal
-
JCEM: Lipoprotein M and Type 2 Diabetes Risk
Time of Update: 2020-07-13
Recent studies have found that lipoprotein M (apoM) plays a role in energy metabolism, and observational analysis of the human body suggests that it is related to type 2 diabetes , but the causal r
